96 related articles for article (PubMed ID: 19889078)
1. Serum levels of leptin as marker for patients at high risk of gastric cancer.
Capelle LG; de Vries AC; Haringsma J; Steyerberg EW; Looman CW; Nagtzaam NM; van Dekken H; ter Borg F; de Vries RA; Kuipers EJ
Helicobacter; 2009 Dec; 14(6):596-604. PubMed ID: 19889078
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
4. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.
Lin JT; Wang JT; Wu MS; Huang SC; Wang TH
Hepatogastroenterology; 1993 Dec; 40(6):600-3. PubMed ID: 8119648
[TBL] [Abstract][Full Text] [Related]
6. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.
Parsonnet J; Samloff IM; Nelson LM; Orentreich N; Vogelman JH; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):461-6. PubMed ID: 8220091
[TBL] [Abstract][Full Text] [Related]
8. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
9. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia.
Tava F; Luinetti O; Ghigna MR; Alvisi C; Perego M; Trespi E; Klersy C; Fratti C; Fiocca R; Solcia E
Hum Pathol; 2006 Nov; 37(11):1489-97. PubMed ID: 16949645
[TBL] [Abstract][Full Text] [Related]
10. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice.
de Vries AC; Haringsma J; de Vries RA; ter Borg F; Nagtzaam NM; Steyerberg EW; van Dekken H; Kuipers EJ
Gastrointest Endosc; 2009 Jul; 70(1):18-25. PubMed ID: 19249770
[TBL] [Abstract][Full Text] [Related]
11. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
12. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
13. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
Ricci C; Vakil N; Rugge M; Gatta L; Perna F; Osborn JF; Russo VM; Tampieri A; Bernabucci V; Miglioli M; Vaira D
Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
[TBL] [Abstract][Full Text] [Related]
14. The non-invasive diagnosis of precancerous changes of stomach mucosa.
Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Polyakova MB; Mernova VP
Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316
[TBL] [Abstract][Full Text] [Related]
15. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
16. Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects.
Russo A; Maconi G; Spinelli P; Felice GD; Eboli M; Andreola S; Ravagnani F; Settesoldi D; Ferrari D; Lombardo C; Bertario L
Am J Gastroenterol; 2001 May; 96(5):1402-8. PubMed ID: 11374674
[TBL] [Abstract][Full Text] [Related]
17. Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection.
Hung KH; Hung HW; Yang HB; Lu CC; Wu JJ; Sheu BS
Helicobacter; 2009 Dec; 14(6):580-7. PubMed ID: 19889076
[TBL] [Abstract][Full Text] [Related]
18. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori infection is associated with reduced circulating ghrelin levels independent of body mass index.
Shiotani A; Miyanishi T; Uedo N; Iishi H
Helicobacter; 2005 Oct; 10(5):373-8. PubMed ID: 16181346
[TBL] [Abstract][Full Text] [Related]
20. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
